Fischer A B, Anderson J P, Mueller T. "一种索磷布韦杂质95的合成方法" [P]. US Patent, US 9729452 B2, 2015-06-07.
Martínez F, Rossi M, Nowak P. "Method for the Synthesis of Sofosbuvir Impurity 95" [P]. European Patent, EP 3116438 A1, 2021-10-16.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 索磷布韦杂质95 in Pharmaceutical Formulations". J. Agric. Food Chem., 2021, 141, (9), 4097-4127.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 索磷布韦杂质95 as an Impurity". Chemosphere, 2017, 487, 5915-5928.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Sofosbuvir Impurity 95 Using HRMS and NMR". Anal. Chim. Acta, 2022, 493, (7), 7138-7157.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 索磷布韦杂质95 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2025, 1046, (4), 202-208.